Work

HM13 is a predictive biomarker of metastasis and neutrophil infiltration in colorectal cancer.

Year: 2025
Type: article
Abstract: BACKGROUND: High levels of histocompatibility minor 13 (HM13) have been related to the progression of several cancers. Here, we investigated the function of HM13 in colorectal cancer (CRC). METHODS: verification of HM13 function. RESULTS: studies further confirmed that MPO overexpression partially abolished the inhibition of tumor growth by sh-HM13 in CRC. CONCLUSION: The results suggested that high HM13 expression in CRC could promote tumor growth and metastasis by reducing neutrophil infiltration and may serve as a useful target in the treatment of metastatic CRC.
Source: PubMed
Language: English
Subfield: Immunology
Open Access status: green
OpenAlex ID: W4405658331
FWCI:
Cites:
Cited by:
Related to: 10